NASDAQ ESPR opened at $1.69 on Thursday. The stock has a market capitalization of $334.36 million, a PE ratio of -2.64 and a beta of 1.04. Esperion Therapeutics has a 1 year low of $1.47 and a 1 ...

ESPERION THERAPEUTICS ($ESPR) is expected to release its quarterly earnings data on Tuesday, March 4th before market open, per Finnhub. Analysts are expecting revenue ...

Esperion (ESPR) announced that following meetings with the U.S. Food and Drug Administration, it has gained alignment on a regulatory path forward for initiating Phase 3 studies of bempedoic acid ...